{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:31:21Z","timestamp":1793745081542,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T00:00:00Z","timestamp":1393200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T00:00:00Z","timestamp":1393200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/bmt.2014.17","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T15:05:30Z","timestamp":1393254330000},"page":"684-690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus"],"prefix":"10.1038","volume":"49","author":[{"given":"J","family":"Labrador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"L\u00f3pez-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"L\u00f3pez-Godino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cabrero-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"D\u00edez-Campelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"S\u00e1nchez-Guijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Alberca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M C","family":"del Ca\u00f1izo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"P\u00e9rez-Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R","family":"Gonz\u00e1lez-Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,24]]},"reference":[{"key":"BFbmt201417_CR1","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation 2010; 90: 918\u2013926.","journal-title":"Transplantation"},{"key":"BFbmt201417_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","volume":"44","author":"JN George","year":"2004","unstructured":"George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB . Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion 2004; 44: 294\u2013304.","journal-title":"Transfusion"},{"key":"BFbmt201417_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","volume":"40","author":"ED Batts","year":"2007","unstructured":"Batts ED, Lazarus HM . Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant 2007; 40: 709\u2013719.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201417_CR4","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S . Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 2011; 118: 1452\u20131462.","journal-title":"Blood"},{"key":"BFbmt201417_CR5","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bmt.2011.65","volume":"46","author":"E Carreras","year":"2011","unstructured":"Carreras E, Diaz-Ricart M . The role of the endothelium in the short-term complications of hematopoietic SCT. Bone Marrow Transplant 2011; 46: 1495\u20131502.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201417_CR6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/asheducation.V2012.1.617.3798924","volume":"2012","author":"CM Nester","year":"2012","unstructured":"Nester CM, Thomas CP . Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated? Hematology Am Soc Hematol Educ Program 2012; 2012: 617\u2013625.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"BFbmt201417_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/CCO.0b013e3280148a2f","volume":"19","author":"K Kojouri","year":"2007","unstructured":"Kojouri K, George JN . Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol 2007; 19: 148\u2013154.","journal-title":"Curr Opin Oncol"},{"key":"BFbmt201417_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ajh.20648","volume":"81","author":"H Nakamae","year":"2006","unstructured":"Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K et al. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. Am J Hematol 2006; 81: 525\u2013531.","journal-title":"Am J Hematol"},{"key":"BFbmt201417_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.bbmt.2005.07.012","volume":"11","author":"GA Hale","year":"2005","unstructured":"Hale GA, Bowman LC, Rochester RJ, Benaim E, Heslop HE, Krance RA et al. Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children. Biol Blood Marrow Transplant 2005; 11: 912\u2013920.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201417_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.transci.2007.03.004","volume":"36","author":"N Worel","year":"2007","unstructured":"Worel N, Greinix HT, Leitner G, Mitterbauer M, Rabitsch W, Rosenmayr A et al. ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy. Transfus Apher Sci 2007; 36: 297\u2013304.","journal-title":"Transfus Apher Sci"},{"key":"BFbmt201417_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/bmt.2009.230","volume":"45","author":"E Willems","year":"2010","unstructured":"Willems E, Baron F, Seidel L, Frere P, Fillet G, Beguin Y . Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplant 2010; 45: 689\u2013693.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201417_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2215\/CJN.02070508","volume":"4","author":"S Changsirikulchai","year":"2009","unstructured":"Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR . Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol 2009; 4: 345\u2013353.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFbmt201417_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.tp.0000297998.33418.7e","volume":"85","author":"K Siami","year":"2008","unstructured":"Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG . Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation 2008; 85: 22\u201328.","journal-title":"Transplantation"},{"key":"BFbmt201417_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.bbmt.2004.03.002","volume":"10","author":"A Shimoni","year":"2004","unstructured":"Shimoni A, Yeshurun M, Hardan I, Avigdor A, Ben-Bassat I, Nagler A . Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced. Biol Blood Marrow Transplant 2004; 10: 484\u2013493.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201417_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1046\/j.1537-2995.2003.00282.x","volume":"43","author":"C Sarkodee-Adoo","year":"2003","unstructured":"Sarkodee-Adoo C, Sotirescu D, Sensenbrenner L, Rapoport AP, Cottler-Fox M, Tricot G et al. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion 2003; 43: 78\u201384.","journal-title":"Transfusion"},{"key":"BFbmt201417_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1097\/TP.0b013e3181ba0a13","volume":"88","author":"D Ghez","year":"2009","unstructured":"Ghez D, Rubio MT, Maillard N, Suarez F, Chandesris MO, Delarue R et al. Rapamycin for refractory acute graft-versus-host disease. Transplantation 2009; 88: 1081\u20131087.","journal-title":"Transplantation"},{"key":"BFbmt201417_CR17","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1182\/blood-2009-03-207563","volume":"115","author":"R Rodriguez","year":"2010","unstructured":"Rodriguez R, Nakamura R, Palmer JM, Parker P, Shayani S, Nademanee A et al. A phase II pilot study of tacrolimus\/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens. Blood 2010; 115: 1098\u20131105.","journal-title":"Blood"},{"key":"BFbmt201417_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","volume":"11","author":"C Cutler","year":"2005","unstructured":"Cutler C, Henry NL, Magee C, Li S, Kim HT, Alyea E et al. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 551\u2013557.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201417_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/01.TP.0000092522.36410.D0","volume":"77","author":"AS Paramesh","year":"2004","unstructured":"Paramesh AS, Grosskreutz C, Florman SS, Gondolesi GE, Sharma S, Kaufman SS et al. Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation. Transplantation 2004; 77: 129\u2013131.","journal-title":"Transplantation"},{"key":"BFbmt201417_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbmt.2012.10.006","volume":"19","author":"S Shayani","year":"2012","unstructured":"Shayani S, Palmer J, Stiller T, Liu X, Thomas SH, Khuu T et al. Thrombotic microangiopathy associated with sirolimus levels following allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based GVHD prophylaxis. Biol Blood Marrow Transplant 2012; 19: 298\u2013304.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201417_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/pbc.22861","volume":"57","author":"J Rosenthal","year":"2011","unstructured":"Rosenthal J, Pawlowska A, Bolotin E, Cervantes C, Maroongroge S, Thomas SH et al. Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus. Pediatr Blood Cancer 2011; 57: 142\u2013146.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt201417_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/bmt.2012.175","volume":"48","author":"SK Khaled","year":"2013","unstructured":"Khaled SK, Palmer J, Stiller T, Senitzer D, Maegawa R, Rodriguez R et al. A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant. Bone Marrow Transplant 2013; 48: 278\u2013283.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201417_CR23","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.bbmt.2010.09.017","volume":"17","author":"LL Rosenbeck","year":"2011","unstructured":"Rosenbeck LL, Kiel PJ, Kalsekar I, Vargo C, Baute J, Sullivan CK et al. Prophylaxis with sirolimus and tacrolimus + antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 916\u2013922.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201417_CR24","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3324\/haematol.2012.067140","volume":"97","author":"J Pidala","year":"2012","unstructured":"Pidala J, Kim J, Jim H, Kharfan-Dabaja MA, Nishihori T, Fernandez H et al. A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation. Haematologica 2012; 97: 1882\u20131889.","journal-title":"Haematologica"},{"key":"BFbmt201417_CR25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3324\/haematol.2012.065599","volume":"98","author":"JA Perez-Simon","year":"2012","unstructured":"Perez-Simon JA, Martino R, Parody R, Cabrero M, Lopez-Corral L, Valcarcel D et al. The combination of Siromilus plus Tacrolimus improves outcome after reduced-intensity conditioning unrelated donor hematopoietic stem cell transplantation compared with Cyclosporine plus Mycofenolate. Haematologica 2012; 98: 526\u2013532.","journal-title":"Haematologica"},{"key":"BFbmt201417_CR26","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201417_CR27","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/S0140-6736(02)08907-9","volume":"359","author":"BC Biedermann","year":"2002","unstructured":"Biedermann BC, Sahner S, Gregor M, Tsakiris DA, Jeanneret C, Pober JS et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 2002; 359: 2078\u20132083.","journal-title":"Lancet"},{"key":"BFbmt201417_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1600-0609.2011.01685.x","volume":"87","author":"O Ringden","year":"2011","unstructured":"Ringden O, Remberger M, Dahllof G, Garming-Legert K, Karlsson H, Svenberg P et al. Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders. Eur J Haematol 2011; 87: 503\u2013509.","journal-title":"Eur J Haematol"},{"key":"BFbmt201417_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 571\u2013575.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201417_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3324\/haematol.10699","volume":"92","author":"T Ruutu","year":"2007","unstructured":"Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 2007; 92: 95\u2013100.","journal-title":"Haematologica"},{"key":"BFbmt201417_CR31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","volume":"41","author":"BS Cho","year":"2008","unstructured":"Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S et al. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 813\u2013820.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201417_CR32","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/bmt.2011.46","volume":"46","author":"JA Lopes","year":"2011","unstructured":"Lopes JA, Jorge S . Acute kidney injury following HCT: incidence, risk factors and outcome. Bone Marrow Transplant 2011; 46: 1399\u20131408.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201417_CR33","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1634\/theoncologist.2009-0067","volume":"14","author":"L Oberic","year":"2009","unstructured":"Oberic L, Buffet M, Schwarzinger M, Veyradier A, Clabault K, Malot S et al. Cancer awareness in atypical thrombotic microangiopathies. Oncologist 2009; 14: 769\u2013779.","journal-title":"Oncologist"},{"key":"BFbmt201417_CR34","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1182\/blood-2010-01-265728","volume":"115","author":"MA Kharfan-Dabaja","year":"2010","unstructured":"Kharfan-Dabaja MA, Pidala J, Anasetti C . Thrombotic microangiopathy after GVHD prophylaxis with tacrolimus\/sirolimus: a call for use of consensus definition in reporting. Blood 2010; 115: 4316\u20134317 author reply 4317.","journal-title":"Blood"},{"key":"BFbmt201417_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","volume":"13","author":"B Oran","year":"2007","unstructured":"Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA et al. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. Biol Blood Marrow Transplant 2007; 13: 469\u2013477.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201417_CR36","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.1002\/cncr.24531","volume":"115","author":"A Gratwohl","year":"2009","unstructured":"Gratwohl A, Stern M, Brand R, Apperley J, Baldomero H, de Witte T et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Cancer 2009; 115: 4715\u20134726.","journal-title":"Cancer"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201417","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201417.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T17:09:17Z","timestamp":1648055357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,24]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["BFbmt201417"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.17","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,24]]},"assertion":[{"value":"13 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}